Cleared Traditional

K832764 - ALPHA NON-INVASIVE BP CARDULE

K832764 is an FDA 510(k) clearance for ALPHA NON-INVASIVE BP CARDULE, manufactured by Spacelabs, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 164-day FDA review.

K832764 · Spacelabs, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
164d
Days
Class 2
Risk

K832764 is an FDA 510(k) clearance for the ALPHA NON-INVASIVE BP CARDULE. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Spacelabs, Inc. (Mchenry, US). The FDA issued a Cleared decision on January 27, 1984 after a review of 164 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Spacelabs, Inc. devices

FDA 510(k) Submission Details - K832764

510(k) Number K832764 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 16, 1983
Decision Date January 27, 1984
Days to Decision 164 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d slower than avg
Panel avg: 125d · This submission: 164d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 565
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K832764.
DRAGER SPHYGMOMED
K840162 · Draeger Medical, Inc. · May 1984
TYCOS SELF CHECK BPM3 BLOOD PRESS MONI
K840469 · Sybron Corp. · May 1984
VERIFORM II
K833583 · American Medical Systems, Inc. · Jan 1984
NARCOTRACE 80
K830338 · Narco Scientific · Dec 1983
DINAMAP VITAL SIGNS MONITOR #1846P
K832656 · Critikon Company, LLC · Nov 1983
ACCU-SPHYG
K832060 · Olympic Medical Corp. · Oct 1983